How is COVID-19 Affecting the FDA? Click here to learn more.
Our agile team of experts is fully mobilized to support you to help keep your operations running smoothly.
How can we help?
Click here to learn more.
About the Weinberg Group
Our Mission and Values
Meet Our Team
News and Events
PROPHARMA GROUP SITE
The World’s Leading FDA Consultants.
DRUGS & BIOTECH
Regulatory Strategy Consulting
End of Phase 2 Meeting
Pre-NDA Meeting Guidance
FDA Advisory Committee Meeting
NDA Submissions: 505(b)(1) & 505(b)(2)
Orphan Drug Designation
Nonclinical Drug Development
Study Design, Placement, & Monitoring
Discovery Stage Assistance
Results Analysis & Design of Follow On Work
Regulatory Due Diligence
QUALITY & COMPLIANCE
Good Clinical Practice (GCP) Services
Good Manufacturing Practices (GMP) Services
Quality Systems & Quality Management
Ready to get started? Have questions?
You can complete the form to get started or contact us at our office.
1129 Twentieth Street NW
Washington, DC 20036